Lululemon stock climbed 1.7% in afternoon trading to $102.30, eking out a tentative recovery after a sharp selloff last week that pushed shares down about 18% following fiscal Q2 2026 results that fell short of expectations.
The company reported revenue of $2.416 billion, a 4% decline from the year-ago period. Comparable sales fell 9%, while the company said sales in its core leggings category declined 20%. A steep reduction to full-year guidance compounded the market reaction, driving the share price toward its 52-week low of $97.99.
With the earnings shock and a wave of analyst price-target reductions largely reflected in the share price, a subset of investors appears to be buying on what they view as an unusually compressed valuation. Barclays kept an Equalweight rating but cut its price target to $95 from $113. UBS trimmed its target to $106 from $120 and maintained a Neutral stance, citing product assortment that is not resonating with consumers and persistently weak traffic. Morgan Stanley lowered its target to $83.
Despite those downward revisions, InvestingPro’s model fair value sits at $163.24, implying a substantial gap between the modeled intrinsic value and the current market price and drawing speculative interest from some market participants.
Wider market movements worked against Lululemon’s advance today - the S&P 500 was down roughly 0.4%, the Dow Jones down about 1.1% and the Nasdaq off near 0.2% - suggesting the stock’s positive move was largely company-specific rather than driven by broader market strength.
The imminent transition in leadership is adding a thin layer of optimism. Incoming CEO Heidi O'Neill is expected to officially assume the role this week, and some investors are viewing her arrival as the start of a "new chapter" that could help address persistent challenges around North American demand, product relevance and headwinds in China sentiment.
Taken together, the trading action looks like a short-term technical stabilization more than a fundamental re-rating. The stock is bouncing from near multi-year lows after an extreme selloff, even as the business continues to contend with declining comparable sales, elevated markdowns and guidance that points to further revenue contraction in upcoming quarters.
Bottom line: Lululemon is experiencing a modest rebound following a deep market correction prompted by weak Q2 fiscal 2026 results and a downgraded outlook. Analyst price-target cuts and an incoming CEO headline investor attention, but the company's underlying sales trends and guidance suggest continued near-term headwinds.